US Broker Ratings

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Unlocking a 40% Potential Upside in Non-Opioid Pain Management Solutions

Investors eyeing opportunities in the healthcare sector may find Pacira BioSciences, Inc. (NASDAQ: PCRX) a compelling option, given its focus on non-opioid pain management and regenerative..

agilon health, inc. (AGL) Stock Analysis: Navigating a 19% Potential Upside Amidst Challenges

For investors with a keen eye on the healthcare sector, agilon health, inc. (NYSE: AGL) presents a complex but intriguing opportunity. Despite some concerning metrics in..

Innoviva, Inc. (INVA) Stock Analysis: Unveiling a Potential 54.91% Upside in the Biotechnology Sector

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the healthcare sector, particularly within the biotechnology industry, is capturing investor attention with its robust growth prospects and..

Structure Therapeutics Inc. (GPCR): Analyst Ratings Suggest Nearly 20% Upside Potential

Structure Therapeutics Inc. (NASDAQ: GPCR), a key player in the biotechnology sector, has captured investor attention with its innovative approach to addressing chronic diseases. With a..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring a Potential 116% Upside in Biotech Innovation

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a prominent player in the biotechnology sector, is making waves within the healthcare industry. The company, based in Hampton, New Jersey,..

Novavax, Inc. (NVAX) Stock Analysis: Assessing a 48% Potential Upside Amidst Market Challenges

Novavax, Inc. (NASDAQ: NVAX), a prominent player in the biotechnology sector, is recognized for its innovative approach to vaccine development. With a market capitalization of $1.41..

Wave Life Sciences Ltd. (WVE): Analyst Consensus Highlights 143.73% Potential Upside for Biotech Innovator

Wave Life Sciences Ltd. (NASDAQ: WVE) is making waves in the biotechnology sector with its innovative approach to RNA medicine development. The Singapore-based clinical-stage company is..

Edgewise Therapeutics (EWTX): Analyst Consensus Reveals a 32% Upside Potential

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a dynamic presence in the biotechnology sector, is drawing significant attention in the investment community. Specializing in the development of therapies..

Integra LifeSciences Holdings C (IART) Stock Analysis: A 38.89% Potential Upside in the Medical Devices Sector

Integra LifeSciences Holdings Corporation (NASDAQ: IART) stands as a notable player in the healthcare sector, specifically within the medical devices industry. Headquartered in Princeton, New Jersey,..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: Exploring a Potential 226.80% Upside

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX), a prominent player in the specialty and generic drug manufacturing industry, presents an intriguing investment opportunity with its potential upside of..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating Market Volatility and Growth Challenges

10x Genomics, Inc. (NASDAQ: TXG) is a prominent player in the healthcare sector, specifically within the health information services industry. The company, headquartered in Pleasanton, California,..

MannKind Corporation (MNKD) Stock Analysis: A Promising 59.92% Upside with Strong Buy Ratings

MannKind Corporation (NASDAQ: MNKD) stands out in the biotechnology sector with its innovative focus on therapeutic products for endocrine and orphan lung diseases. Based in Danbury,..

Schrodinger, Inc. (SDGR) Investor Outlook: Unveiling a 77.43% Potential Upside Amidst Innovative Drug Discovery and Software Growth

Schrodinger, Inc. (NASDAQ: SDGR), a pivotal player in the healthcare sector’s Health Information Services industry, is capturing investor attention with a striking 77.43% potential upside. This..

PACS Group, Inc. (PACS)

⚠️ No article content returned.

..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a 16% Potential Upside

Kestra Medical Technologies, Ltd. (KMTS) stands at the intersection of healthcare innovation and investment opportunity. This Kirkland, Washington-based company, with a market capitalization of $1.46 billion,..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: A Promising 37.97% Upside Awaits Investors

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a notable player in the healthcare industry, specifically within the drug manufacturing sector, presents an intriguing opportunity for investors seeking growth..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Exploring a Potential 25.73% Upside with Promising CNS Portfolio

Supernus Pharmaceuticals, Inc. (SUPN), a prominent player in the healthcare sector, specializes in developing and commercializing innovative treatments for central nervous system (CNS) diseases. With a..

Agios Pharmaceuticals (AGIO): Investor Outlook on a Biotech with 30.5% Upside Potential

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is making waves in the biotechnology sector with its innovative approach to cellular metabolism and promising pipeline of treatments. With a..

LivaNova PLC (LIVN) Stock Analysis: Promising 9.35% Upside as Healthcare Innovator Surges

LivaNova PLC (NASDAQ: LIVN), the UK-based medical device company, is making waves in the healthcare sector with a robust growth trajectory and an impressive market capitalization..

CONMED Corporation (CNMD) Stock Analysis: Exploring a 23.95% Potential Upside in the Medical Devices Sector

CONMED Corporation (NASDAQ: CNMD), a key player in the healthcare sector’s medical devices industry, offers intriguing investment potential with a notable 23.95% upside based on current..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds